Jun 13, 2022 / 12:00PM GMT
Operator
Ladies and gentlemen, thank you for standing by. Welcome to the Gracell Biotechnologies Clinical Update Conference Call that is being held at the European Hematology Association 2022 Hybrid Congress. (Operator Instructions) I will now turn the conference call over to Rebecca Rodriguez, ICR Westwicke Investor Relations. Go ahead.
Rebecca Rodriguez -
Good morning, and welcome to Gracell's Clinical Update Conference Call and Webcast. With me today are Gracell's Founder and Chief Executive Officer, Dr. William Chao; Chief Medical Officer, Dr. Martina Sersch; and Chief Financial Officer, Dr. Kevin Xie.
The team is excited to discuss the clinical data from 3 investigator-initiated studies that were shared at European Hematology Association 2022 Hybrid Congress. After our formal remarks, we will conduct a question-and-answer session.
Gracell presented 3 clinical updates over the past few days at ASCO and EHA2022 Annual Meeting and issued 2 press releases highlighting the data. We encourage everyone to read these press releases and would also like to remind
Gracell Biotechnologies Inc Clinical Update Call After EHA2022 Transcript
Jun 13, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers